Zoetis Inc. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,561
4,785
4,765
4,888
5,307
5,825
Cost of Goods Sold (COGS) incl. D&A
1,707
1,745
1,772
1,732
1,851
2,028
Gross Income
2,854
3,040
2,993
3,156
3,456
3,797
SG&A Expense
1,820
1,907
1,797
1,703
1,714
1,916
EBIT
1,034
1,133
1,196
1,453
1,742
1,881
Unusual Expense
215
191
430
100
61
56
Non Operating Income/Expense
16
5
97
41
19
46
Interest Expense
113
117
124
166
175
212
Pretax Income
690
820
545
1,228
1,525
1,690
Income Tax
187
233
206
409
663
266
Consolidated Net Income
503
587
339
819
862
1,424
Net Income
504
583
339
821
864
1,428
Net Income After Extraordinaries
504
583
339
821
864
1,428
Net Income Available to Common
504
583
339
821
864
1,428
EPS (Basic)
1.01
1.16
0.68
1.65
1.75
2.93
Basic Shares Outstanding
500
501
500
496
490
483
EPS (Diluted)
1.01
1.16
0.68
1.65
1.75
2.93
Diluted Shares Outstanding
500
502
502
498
493
487
EBITDA
1,243
1,337
1,395
1,693
1,984
2,189
Minority Interest Expense
1
4
-
2
2
4

About Zoetis

View Profile
Address
10 Sylvan Way
Parsippany New Jersey 07054
United States
Employees -
Website http://www.zoetis.com
Updated 07/08/2019
Zoetis, Inc. discovers, develops and manufactures a portfolio of animal health medicines and vaccines. Its products are complemented by diagnostic products, genetic tests, bio devices and services. These are designed to meet the needs of veterinarians and the livestock farmers and companion animal.